The pathogenesis of and new classification criteria for MAS
Search results for: tocilizumab
Can DIY Medicine Tame Rampaging Healthcare Costs?
High health insurance deductibles, physician charges, medication expenses spur patients to seek less costly lab testing, surgical procedures, prescription drugs
Giant Cell Arteritis Challenging to Diagnose, Manage
Common form of primary vasculitis difficult to identify, treat, but latest research suggests potential new therapeutic targets
2014 ACR/ARHP Annual Meeting: Fibrotic Complications of Scleroderma
Rheumatology experts discuss challenge of selecting appropriate SSc patients with skin fibrosis for treatment
Biomarkers in Rheumatoid Arthritis Remain Elusive
Biomarkers to assess disease progression are in use, but none can predict which therapy will work best for each patient
Biomarkers to Guide Diagnosis, Treatment of Rheumatic Diseases
Examining the usefulness, drawbacks of current biomarkers in rheumatology and progress to develop better ones
Drugs Studied for Use in Rheumatoid Arthritis, Weight Loss
Plus, rheumatology drug news from EULAR 2014
Rheumatology Drug Updates, Trials, Safety Data
An update on baricitinib, plus safety warnings on belimumab,
eszopiclone and zoledronic acid
What’s New in Inflammatory Arthritis?
Rheumatology experts at the ACR’s State-of-the-Art Clinical Symposium in Chicago discuss latest drug therapies, insights into axial spondyloarthritis and bone erosion, repair
Fellow’s Forum Case Report: Takayasu’s Arteritis
How this rare form of large-vessel vasculitis affects different portions, branches of aorta and ways to diagnose, treat and manage the disease
- « Previous Page
- 1
- …
- 24
- 25
- 26
- 27
- 28
- …
- 30
- Next Page »